United states securities and exchange commission

204

Rohm and Haas Electronic Materials Taiwan Ltd.	Taiwan
Rohm and Haas International Trading (Shanghai) Co. Ltd.	China
Rohm and Haas Italia S.r.l.	Italy
Rohm and Haas Mexico, S. de R.L. de C.V.	Mexico
Rohm and Haas Quimica Ltda.	Brazil
Rohm and Haas Shanghai Chemical Industry Co., Ltd.	China
Rohm and Haas Singapore (Pte.) Ltd.	Singapore
Rohm and Haas Taiwan, Inc.	Taiwan
Rohm and Haas Texas Incorporated	Texas
Rohm and Haas Wood Treatment LLC	Delaware
Specialty Electronic Materials UK Limited	United Kingdom
Union Carbide Corporation	New York
Univation (Zhangjiagang) Chemical Company Limited	China
Univation Technologies, LLC	Delaware
Valley Asset Leasing, LLC	Delaware
Zhejiang OMEX Environmental Engineering Co., Ltd.	China
Zhejiang Pacific Chemical Corporation	China
DuPont Subsidiaries	Organized Under Laws Of
E.I. du Pont de Nemours and Company	Delaware
Belco Technologies Corporation	Delaware
DPC (Luxembourg) SARL	Luxembourg
DPNL BV	The Netherlands
Du Pont (Australia) PTY LTD.	Australia
Du Pont Agricultural Chemicals Ltd., Shanghai	China
Du Pont China Limited (US)	Delaware
Du Pont de Nemours (Belgium) BVBA	Belgium
Du Pont de Nemours Italiana S.r.l.	Italy
Du Pont Feedstocks Company	Delaware
DuPont (China) Research & Development and Management Co., Ltd.	China
DuPont (Korea) Inc.	Korea
DuPont (Thailand) Limited	Thailand
DuPont (U.K.) Industrial Limited	United Kingdom
DuPont (U.K.) Limited	United Kingdom
DuPont (U.K.) Ltd.	United Kingdom
DuPont Acquisition (Luxembourg) S.a.r.l.	Luxembourg
DuPont Acquisition, LLC	Delaware
DuPont Apollo (Shenzhen) Limited	China
DuPont Argentina S.R.L.	Argentina
DuPont Asturias, S.L.	Spain
DuPont Belgium North America Finance Company	Belgium
DuPont BVco BV	The Netherlands
DuPont Capital Management Corporation	Delaware
DuPont Chemical and Energy Operations, Inc.	Delaware
DuPont China Holding Company Ltd.	China
DuPont China Limited	Hong Kong
DuPont Company (Singapore) Pte Ltd.	Singapore
DuPont Contern (Luxembourg) SARL	Luxembourg
DuPont Coordination Center N.V.	Belgium
DuPont DACI Beteiligungs-GmbH	Austria
DuPont de Nemours (Deutschland) GmbH	Germany
DuPont de Nemours (France) S.A.S.	France
DuPont de Nemours (Luxembourg) S.a.r.l.	Luxembourg
DuPont de Nemours (Luxembourg) SARL	Luxembourg

205

DuPont de Nemours (Nederland) B.V.	The Netherlands
DuPont de Nemours Groupe SAS	France
DuPont de Nemours Holding Sarl (LLC)	Switzerland
DuPont de Nemours International S.a.r.l.	Switzerland
DuPont de Nemours International Sarl	Switzerland
DuPont Denmark Holding ApS	Denmark
DuPont Deutschland Holding GmbH & Co. KG	Germany
DuPont do Brasil S.A.	Brazil
DuPont Eastern Europe BV	The Netherlands
DuPont Electronic Polymers LP	Delaware
DuPont Electronics Microcircuits Industries, Ltd.	Bermuda
DuPont Energy Company, LLC	Delaware
DuPont Global Operations, Inc.	Delaware
DuPont Iberica, S.L.	Spain
DuPont International (Luxembourg) SCA	Luxembourg
DuPont International B.V.	The Netherlands
DuPont International Operations S.a r.l.	Switzerland
DuPont Kabushiki Kaisha	Japan
DuPont KGA B.V.	The Netherlands
DuPont Mexico S.A. de C.V.	Mexico
DuPont Nutrition Biosciences ApS	Denmark
DuPont Nutrition USA, Inc.	Delaware
DuPont Operations Worldwide, Inc.	Delaware
DuPont Operations, Inc.	Delaware
DuPont Products (Luxembourg) SARL	Luxembourg
DuPont Science (Luxembourg) S.a r.l.	Luxembourg
DuPont Solutions (Luxembourg) SARL	Luxembourg
DuPont Specialty Products Kabushiki Kaisha	Japan
DuPont Taiwan Limited	Taiwan
DuPont Technology (Luxembourg) S.a.r.l.	Luxembourg
DuPont Teijin Films China LTD.	Hong Kong
DuPont Trading (Shanghai) Co., Ltd.	China
DuPont Xingda Filaments Company Limited	China
E.I. DuPont Canada Company	Canada
E.I. DuPont Canada- Thetford Inc.	Canada
E.I. DuPont India Private Limited	India
EKC Technology, Inc.	California
FCC Acquisition Corporation	California
FMC Biopolymer AS	Norway
FMC Manufacturing Limited	Ireland
Hickory Holdings, Inc.	Delaware
Howson Algraphy BV	The Netherlands
MECS Inc.	Delaware
Pioneer Hi-Bred International, Inc.	Iowa
Shenzhen DuPont Performance Materials Investment Co., Ltd.	China
Solae L.L.C.	Delaware
SP EMEA Holding 7 B.V.	The Netherlands
SP Luxembourg, LLC	Delaware
Spruance Genco, LLC	Delaware

Subsidiaries not listed would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary.

206

	Consent of Independent Registered Public Accounting Firm	EXHIBIT 23.1

We consent to the incorporation by reference in Registration Statements No. 333-220324 and 333-220330 on Forms S-8 of our reports dated February 15, 2018, relating to (1) the consolidated financial statements and financial statement schedule of DowDuPont Inc. and subsidiaries (the “Company”), (which report expresses an unqualified opinion on those financial statements and financial statement schedule and includes an explanatory paragraph regarding a change in accounting policy related to asbestos-related defense and processing costs and an emphasis of a matter paragraph regarding the merger of The Dow Chemical Company and E. I. du Pont de Nemours and Company), and (2) the effectiveness of the Company's internal control over financial reporting as of December 31, 2017, appearing in this Annual Report on Form 10-K of DowDuPont Inc. for the year ended December 31, 2017.

/s/ DELOITTE & TOUCHE  LLP

Deloitte & Touche  LLP

Midland, Michigan

February 15, 2018

207

	Consent of Independent Registered Public Accounting Firm	EXHIBIT 23.2

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8s (Nos. 333-220330 and 333-220324) of DowDuPont Inc. of our Successor report dated February 15, 2018 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting of E. I du Pont de Nemours and Company, which appears in this Annual Report on Form 10-K of DowDuPont Inc.

/s/ PRICEWATERHOUSECOOPERS LLP

PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 15, 2018

208

	Ankura Consulting Group, LLC's Consent	EXHIBIT 23.3

DowDuPont Inc.:

Ankura Consulting Group, LLC ("Ankura") hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Annual Report on Form 10-K of DowDuPont Inc. for the year ended December 31, 2017 , and the incorporation by reference thereof in the following Registration Statements of DowDuPont Inc.:

Form S-8:
Nos.	333-220330
	333-220324

/s/ B. THOMAS FLORENCE

B. Thomas Florence

Senior Managing Director

Ankura Consulting Group, LLC

February 15, 2018

209

		DowDuPont Inc.		EXHIBIT 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Edward D. Breen, certify that:

1.	I have reviewed this annual report on Form 10-K of DowDuPont Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)		designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)		designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)		evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)		disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
a)		all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)		any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 15, 2018

 

/s/ EDWARD D. BREEN

Edward D. Breen

Chief Executive Officer